Cullinan Therapeutics, Inc. (CGEM)
(Delayed Data from NSDQ)
$28.35 USD
+0.77 (2.79%)
Updated May 3, 2024 04:00 PM ET
After-Market: $28.34 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Earnings News For CGEM
-
Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
-
Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
-
Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
-
Cullinan Oncology Provides Corporate Update and Reports First Quarter 2023 Financial Results
-
Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
-
Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2022 Financial Results